The Patent Finder

Zymeworks Biopharmaceuticals Inc.

Also on record
Records under this name other than patents Zymeworks Biopharmaceuticals Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 6 of 6 · Back to Zymeworks Biopharmaceuticals Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 11,000,598Anti-HER2 biparatopic antibody-drug conjugates and methods of use
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 12,357,701Anti-HER2 biparatopic antibody-drug conjugates and methods of use
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 12,435,157Methods of Using a Bispecific Antigen-Binding Construct Targeting HER2 for the Treatment of Biliary Tract Cancers
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 12,076,400Methods of using a bispecific antigen-binding construct targeting HER2 in combination with CDK4/6 inhibitors for the treatment of breast cancer
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 12,433,952Antibody-Drug Conjugates Targeting Folate Receptor Alpha and Methods of Use
Formerly held
In force
 · High confidence
In forceHigh confidence
US 12,304,954Multivalent and Bispecific Antibody Constructs and Methods of Use Thereof
Formerly held
In force
 · High confidence
In forceHigh confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited